Saratchandra Singh Khumukcham
University of Hyderabad
H-index: 6
Asia-India
Top articles of Saratchandra Singh Khumukcham
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
HPIP and RUFY3 are noncanonical guanine nucleotide exchange factors of Rab5 to regulate endocytosis-coupled focal adhesion turnover | Journal of Biological Chemistry | Saratchandra Singh Khumukcham Vasudevarao Penugurti Suresh Bugide Anju Dwivedi Anita Kumari | 2023/11/1 |
Colorectal cancer immunotherapy: state of the art and future directions | Alyssa Mauri Cornista Maria Virginia Giolito Kristi Baker Hajar Hazime Inès Dufait | 2023/9/19 | |
NARRATIVE REVIEWS | Alyssa Mauri Cornista Maria Virginia Giolito Kristi Baker Hajar Hazime Inès Dufait | 2023 | |
Triumvirate's of HPIP, RUFY3, and RAB5: a Cellular Ballet in Cancer Cell Migration | 1. ISCB office bearers for the term 2023-2025 1 2. Presidential remarks 2 3. Message from Secretary 3 4. Message from Executive Secretary 4 5. XLV All India Cell Biology Conference & International Symposium on Biology of Development and | Saratchandra Singh Khumukcham Bramanandam Manavathi | 2023/12/31 |
Hematopoietic PBX‐interacting protein is a novel regulator of mammary epithelial cell differentiation | The FEBS Journal | Anju Dwivedi Chiranjeevi Padala Anita Kumari Saratchandra Singh Khumukcham Vasudevarao Penugurti | 2022/3 |
A reciprocal feedback loop between HIF-1α and HPIP controls phenotypic plasticity in breast cancer cells | Cancer Letters | Saratchandra Singh Khumukcham Vasudevarao Penugurti Anita Soni Veena Uppala Kishore Hari | 2022/2/1 |
HPIP protooncogene differentially regulates metabolic adaptation and cell fate in breast cancer cells under glucose stress via AMPK and RNF2 dependent pathways | Cancer letters | Vasudevarao Penugurti Saratchandra Singh Khumukcham Chiranjeevi Padala Anju Dwivedi Karthik Reddy Kamireddy | 2021/10/10 |
Two decades of a protooncogene HPIP/PBXIP1: uncovering the tale from germ cell to cancer | Saratchandra Singh Khumukcham Bramanandam Manavathi | 2021/8/1 | |
Effective in vitro delivery of paclitaxel by nanocargo of mesoporous polycaprolactone against triple negative breast cancer cells by minimalizing drug dose | RSC advances | Himadri Medhi Saratchandra Singh Khumukcham Bramanandam Manavathi Pradip Paik | 2020 |
